Dr. Jay Michael Zelinski, DO

Dr. Zelinski practices at Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey.

Dr. Zelinski's NPI, 1184806309, was assigned on November 29, 2007. Dr. Zelinski holds New Jersey license 25MB04874100.

Dr. Zelinski's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD, at 200 S Orange Ave, Livingston, NJ 07039.

Dr. Zelinski's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey. Dr. Zelinski is also affiliated with Community Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Zelinski to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zelinski practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Zelinski's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Zelinski is licensed in New Jersey.

CMS data shows 60 Medicare services from Dr. Zelinski across 2 procedure codes in 2024, all of them office visits, for 53 Medicare patients. Medicare paid $6,333 for them. Every service was in an office.

CMS counts 53 Medicare patients who saw Dr. Zelinski in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zelinski's median patient age at 67, with 49% women.

In 2024, Dr. Zelinski wrote 349 Medicare Part D claims for 82 patients. 89% of them were for generic drugs. CMS names the drug for 249 of them, across 9 drugs with 11 or more claims each, at $25,256 in total drug cost. In 2023, CMS named 391 claims across 15 drugs.

Dr. Zelinski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 4 general payments to Dr. Zelinski from 3 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 86% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $725.